- Scrip Originals
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Nuvalent, Inc.
Private Company Edition: The venture capital firm said it will back biopharma, diagnostics and other opportunities in health care. In addition to the Design and TScan mega-rounds, Verve raised $94m, Vera garnered $80m and Ixaka (formerly Rexgenero) closed a £40m ($54.7m) financing.
- Site Specific
- Drug Delivery